Literature DB >> 2362449

Potency and selectivity of the aromatase inhibitor R 76,713. A study in human ovarian, adipose stromal, testicular and adrenal cells.

W Wouters1, R De Coster, D Beerens, R Doolaege, J A Gruwez, K Van Camp, H Van Der Pas, B van Herendael.   

Abstract

The effects of R 76,713 on steroidogenesis were studied in primary cultures of four different human cell types, i.e. ovarian granulosa cells, adipose stromal cells, testicular cells and adrenal cells. In human granulosa cells aromatization of [1 beta, 2 beta-3H]androstenedione (as measured by the release of tritiated water) showed a Km (Michaelis constant) of 78 nM. R 76,713 competitively inhibited aromatization with a Ki (dissociation constant of the enzyme-inhibitor complex) of 1.6 nM. In human adipose stromal cells aromatization was measured by following the conversion of androstenedione to estrone and 17 beta-estradiol. In this system a Km for aromatization of androstenedione of 10.8 nM was found. R 76,713 again showed competitive kinetics with a Ki-value of 0.14 nM. In human testicular cells the synthesis of the androgens testosterone, androstenedione and dehydroepiandrosterone was only inhibited by drug concentrations exceeding 10(-6) M. At 10(-5) M of R 76,713, steroid concentrations were lowered to 56, 64 and 81% of the control for testosterone, androstenedione and dehydroepiandrosterone respectively. Concomitantly, a slight increase in the levels of pregnenolone (138% of the control) and progesterone (133% of the control) was seen. In human adrenal cells the synthesis of cortisol and aldosterone was slightly affected by R 76,713 also at concentrations exceeding 10(-6) M. At 10(-5) M of R 76,713 the concentrations of cortisol and aldosterone were lowered to respectively 59 and 51% of the control. At the same drug concentration the precursors 11-deoxycortisol and 11-deoxycorticosterone rose to 189 and 147% of the control. These results show that in primary cultures of human cells, R 76,713 is a very potent aromatase inhibitor with a selectivity of at least 1000-fold compared to other steps in steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362449     DOI: 10.1016/0022-4731(90)90113-7

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  4 in total

Review 1.  Aromatase and its inhibitors in breast cancer treatment--overview and perspective.

Authors:  A M Brodie; R J Santen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 2.  Aromatase inhibitors--mechanisms for non-steroidal inhibitors.

Authors:  H V Vanden Bossche; H Moereels; L M Koymans
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 3.  Vorozole, a specific non-steroidal aromatase inhibitor.

Authors:  W Wouters; E Snoeck; R De Coster
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Determining the IC 50 Values for Vorozole and Letrozole, on a Series of Human Liver Cytochrome P450s, to Help Determine the Binding Site of Vorozole in the Liver.

Authors:  Lendelle Raymond; Nikita Rayani; Grace Polson; Kylie Sikorski; Ailin Lian; Melissa A VanAlstine-Parris
Journal:  Enzyme Res       Date:  2015-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.